- Home
- MLSS vs VERU Comparison
MLSS vs VERU Comparison
Compare MLSS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- VERU
- Stock Information
- Founded
- MLSS 1989
- VERU 1971
- Country
- MLSS United States
- VERU United States
- Employees
- MLSS N/A
- VERU N/A
- Industry
- MLSS Industrial Specialties
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- VERU Health Care
- Exchange
- MLSS Nasdaq
- VERU Nasdaq
- Market Cap
- MLSS 42.4M
- VERU 40.6M
- IPO Year
- MLSS 1995
- VERU 1990
- Fundamental
- Price
- MLSS $0.31
- VERU $2.46
- Analyst Decision
- MLSS Buy
- VERU Strong Buy
- Analyst Count
- MLSS 1
- VERU 2
- Target Price
- MLSS $1.00
- VERU $25.00
- AVG Volume (30 Days)
- MLSS 3.2M
- VERU 191.7K
- Earning Date
- MLSS 11-13-2025
- VERU 12-15-2025
- Dividend Yield
- MLSS N/A
- VERU N/A
- EPS Growth
- MLSS N/A
- VERU N/A
- EPS
- MLSS N/A
- VERU N/A
- Revenue
- MLSS $8,929,517.00
- VERU $16,886,419.00
- Revenue This Year
- MLSS $16.06
- VERU N/A
- Revenue Next Year
- MLSS $14.73
- VERU N/A
- P/E Ratio
- MLSS N/A
- VERU N/A
- Revenue Growth
- MLSS 0.59
- VERU 337.24
- 52 Week Low
- MLSS $0.28
- VERU $2.11
- 52 Week High
- MLSS $1.39
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- MLSS 34.23
- VERU 39.17
- Support Level
- MLSS $0.28
- VERU $2.11
- Resistance Level
- MLSS $0.32
- VERU $2.57
- Average True Range (ATR)
- MLSS 0.04
- VERU 0.20
- MACD
- MLSS -0.00
- VERU 0.02
- Stochastic Oscillator
- MLSS 20.58
- VERU 50.60
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.